318 related articles for article (PubMed ID: 16642639)
1. Mortality in a complete 4-year follow up of 85-year-old residents of Leiden, classified by serum level of thyrotropin and thyroxine.
Singer RB
J Insur Med; 2006; 38(1):14-9. PubMed ID: 16642639
[TBL] [Abstract][Full Text] [Related]
2. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM
Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid function, activities of daily living and survival in extreme old age: the 'Leiden 85-plus Study'].
Gussekloo J; van Exel E; de Craen AJ; Meinders AE; Frölich M; Westendorp RG
Ned Tijdschr Geneeskd; 2006 Jan; 150(2):90-6. PubMed ID: 16440564
[TBL] [Abstract][Full Text] [Related]
4. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians.
Meyerovitch J; Rotman-Pikielny P; Sherf M; Battat E; Levy Y; Surks MI
Arch Intern Med; 2007 Jul; 167(14):1533-8. PubMed ID: 17646608
[TBL] [Abstract][Full Text] [Related]
5. Thyroid status, disability and cognitive function, and survival in old age.
Gussekloo J; van Exel E; de Craen AJ; Meinders AE; Frölich M; Westendorp RG
JAMA; 2004 Dec; 292(21):2591-9. PubMed ID: 15572717
[TBL] [Abstract][Full Text] [Related]
6. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
[TBL] [Abstract][Full Text] [Related]
7. [Subclinical thyroid disease--should we treat, should we screen for it?].
Trbojević B
Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
9. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
10. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
Singer RB
J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thyroid disease in an older Australian population.
Empson M; Flood V; Ma G; Eastman CJ; Mitchell P
Intern Med J; 2007 Jul; 37(7):448-55. PubMed ID: 17547723
[TBL] [Abstract][Full Text] [Related]
12. Elevations of thyroid-stimulating hormone during acute nonthyroidal illness.
Wong ET; Bradley SG; Schultz AL
Arch Intern Med; 1981 Jun; 141(7):873-5. PubMed ID: 7235805
[TBL] [Abstract][Full Text] [Related]
13. Screening for thyroid disease in the elderly. Serum concentrations of thyrotropin and 3,5,3'-triiodothyronine in a representative population of 79-year-old women and men.
Edén S; Sundbeck G; Lindstedt G; Lundberg PA; Jagenburg R; Landahl S; Svanborg A
Compr Gerontol A; 1988 Feb; 2(1):40-5. PubMed ID: 3197053
[TBL] [Abstract][Full Text] [Related]
14. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
Sawin CT; Geller A; Kaplan MM; Bacharach P; Wilson PW; Hershman JM
Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
[TBL] [Abstract][Full Text] [Related]
15. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
Rana S; Nunlee-Bland G; Valyasevi R; Iqbal M
Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
[TBL] [Abstract][Full Text] [Related]
16. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus.
Milano AF; Singer RB
J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374
[TBL] [Abstract][Full Text] [Related]
17. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators.
Krahn AD; Klein GJ; Kerr CR; Boone J; Sheldon R; Green M; Talajic M; Wang X; Connolly S
Arch Intern Med; 1996 Oct; 156(19):2221-4. PubMed ID: 8885821
[TBL] [Abstract][Full Text] [Related]
18. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study.
O'Leary PC; Feddema PH; Michelangeli VP; Leedman PJ; Chew GT; Knuiman M; Kaye J; Walsh JP
Clin Endocrinol (Oxf); 2006 Jan; 64(1):97-104. PubMed ID: 16402936
[TBL] [Abstract][Full Text] [Related]
19. High incidence of occult thyroid disease among general medical ward patients.
Arber N; Schapiro JM; Lapidot M; Benosh L; Lubin E; Pinkhas J; Sidi Y
J Med; 1995; 26(3-4):139-51. PubMed ID: 8558095
[TBL] [Abstract][Full Text] [Related]
20. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study.
Heeringa J; Hoogendoorn EH; van der Deure WM; Hofman A; Peeters RP; Hop WC; den Heijer M; Visser TJ; Witteman JC
Arch Intern Med; 2008 Nov; 168(20):2219-24. PubMed ID: 19001198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
